Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Respiratory Syncytial Virus Test
29 Jul 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it received a U.S. Food and Drug Administration (FDA) 510(k) clearance to market...
More...
  Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer
10 Jun 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) is pleased to announce that Livleen Kaler has been appointed Vice President Finance & Administration...
More...
  Response Biomedical Closes $12.65 million Unit Offering
21 May 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has closed its previously announced public offering of units for gross proceeds of...
More...
  Response Biomedical Announces Terms of Unit Offering
07 May 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an underwriting agreement with Haywood Securities Inc...
More...
  Response Biomedical Announces Proposed Unit Offering
05 May 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced that it has filed a preliminary short form prospectus in each of the provinces and...
More...
  Response Biomedical Corporation Announced First Quarter Results
05 May 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $2,712,401 and a net loss of $1,731,415 or ($0.01) per...
More...
  Response Biomedical Corporation Files for U.S. FDA 510(k) Market Clearance of its Rapid Respiratory Syncytial Virus Test
28 Apr 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has filed a U.S. Food and Drug Administration (FDA) 510(k) submission seeking...
More...
  Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
20 Apr 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced preliminary unaudited revenues for the three-month period ended March 31, 2009...
More...
  Response Biomedical Corporation Reports 2008 Financial Results
30 Mar 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF)reported that it recorded total revenues of $5,876,337 and and a net loss of...
More...
  Response Biomedical Announces Breakthrough Collaboration with FIND for TB Point-of-Care Development
26 Mar 2009
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF)announced that it has signed a collaboration/grant with FIND (Foundation for Innovative New Diagnostics) ...
More...